ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 127 filers reported holding ALLAKOS INC in Q2 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,937 | -53.1% | 1,591 | -52.2% | 0.00% | – |
| Q1 2023 | $14,796 | -56.1% | 3,325 | -16.9% | 0.00% | -100.0% |
| Q4 2022 | $33,672 | +77.2% | 3,999 | +28.5% | 0.00% | 0.0% |
| Q3 2022 | $19,000 | +216.7% | 3,113 | +202.8% | 0.00% | – |
| Q1 2022 | $6,000 | +500.0% | 1,028 | +703.1% | 0.00% | – |
| Q4 2021 | $1,000 | -66.7% | 128 | +341.4% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 29 | -3.3% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 30 | -14.3% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 35 | +29.6% | 0.00% | – |
| Q4 2020 | $4,000 | +33.3% | 27 | -18.2% | 0.00% | – |
| Q3 2020 | $3,000 | +50.0% | 33 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |